IL17A and systemic lupus erythematosus: In a humanized mouse model of SLE, adoptive transfer of MDSCs from human SLE patients promoted IL-17 production, accompanied by nephritis and anti-dsDNA antibodies in mice, leading to increased clinical symptoms (8).